Ozurdex Implant for Macular Edema After Treatment Failure With Anti-VEGF
Dexamethasone Intravitreal Implant for Retinal Vein Occlusion Associated Macular Edema After Treatment Failure With Anti-VEGF Medications
Sponsor: Retina Research Institute, LLC
Terminated
enrollment not met
Other Macular Edema trials with similar outcome
Listed as NCT01946399, this NA trial focuses on Macular Edema and Retinal Vein Occlusion (RVO) and remains terminated or withdrawn. Sponsored by Retina Research Institute, LLC, it has been updated 9 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Sep 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
▶ Show 4 earlier versions
-
Dec 2017 — Jun 2018 [monthly]
Terminated NA
-
Nov 2017 — Dec 2017 [monthly]
Terminated NA
-
Feb 2017 — Nov 2017 [monthly]
Terminated NA
-
Jan 2017 — Feb 2017 [monthly]
Terminated NA
First recorded
Sep 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Retina Research Institute, LLC
- Retina-Vitreous Associates Medical Group
- West Coast Retina Medical Group, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .